AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 244: G683-G688, 1983;
0193-1857/83 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Otsuki, M.
Right arrow Articles by Williams, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Otsuki, M.
Right arrow Articles by Williams, J. A.

AJP - Gastrointestinal and Liver Physiology, Vol 244, Issue 6 683-G688, Copyright © 1983 by American Physiological Society


ARTICLES

Amylase secretion by isolated pancreatic acini after chronic cholecystokinin treatment in vivo

M. Otsuki and J. A. Williams

Rats were given subcutaneous injections of synthetic cholecystokinin octapeptide (CCK8, 5 micrograms/kg) in a depot carrier twice daily for 7-14 days. The pancreatic wet weight increased by 20.6 and 30.9% in the rats treated with CCK8 for 7 and 14 days, respectively. The increase in pancreatic weight was associated with an increase in the amount of protein per DNA, indicating hypertrophy of the acinar cells, and with an increase in the total amount of pancreatic DNA. Moreover, CCK administration also increased the amylase content per DNA. In acini prepared from CCK8-treated rats, responsiveness to CCK8 was increased when amylase release was expressed relative to DNA but was decreased when calculated as the percentage of the initial content in the acini. The dose-response curves for CCK8 were similarly shaped in both CCK8-treated and control rats, but they were shifted 3- to 10-fold toward higher concentrations of CCK8 after 7 and 14 days of CCK8 treatment. There were no major changes in the affinity and capacity of CCK receptors determined by studying the binding of radioiodinated CCK, suggesting that alterations in pancreatic amylase release were due to changes at a postreceptor loci. In support of this hypothesis, the secretory response to carbachol, known to act on a different receptor but by a common intracellular mechanism, was altered in a manner identical to the response to CCK8. Thus chronic stimulation with CCK sufficient to induce pancreatic hypertrophy does not greatly alter CCK receptors and induces only moderate postreceptor desensitization.


This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Yamamoto, M. Otani, D.-M. Jia, K.-I. Fukumitsu, H. Yoshikawa, T. Akiyama, and M. Otsuki
Differential mechanism and site of action of CCK on the pancreatic secretion and growth in rats
Am J Physiol Gastrointest Liver Physiol, October 1, 2003; 285(4): G681 - G687.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. M. Jia, K.-I. Fukumitsu, A. Tabaru, T. Akiyama, and M. Otsuki
Troglitazone stimulates pancreatic growth in congenitally CCK-A receptor-deficient OLETF rats
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2001; 280(5): R1332 - R1340.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Covasa, J. K. Marcuson, and R. C. Ritter
Diminished satiation in rats exposed to elevated levels of endogenous or exogenous cholecystokinin
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2001; 280(2): R331 - R337.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online